[Therapeutic and toxicologic problems in the therapy of nonspecific urinary tract infections with impaired kidney function].
D000900:Anti-Bacterial Agents / Q000097:blood / Q000652:urine; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D002512:Cephalothin / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D007677:Kidney Function Tests; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D009268:Nalidixic Acid; D009582:Nitrofurantoin; D002512:Cephalothin
Therapeutische und toxikologische Probleme in der Behandlung unspezifischer Harnwegsinfektionen bei eingeschränkter Nierenfuntion.